4basebio wins deal to supply clinical-grade DNA for pharma client trial
The company will supply clinical-grade opDNA starting material for a multinational pharmaceutical company’s Phase I cell therapy trial.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The company will supply clinical-grade opDNA starting material for a multinational pharmaceutical company’s Phase I cell therapy trial.